The BioXcel Therapeutics Inc stock price today is What Is the Stock Symbol for BioXcel Therapeutics Inc? The stock ticker symbol for BioXcel Therapeutics. BTAI - BioXcel Therapeutics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqCM). On average, Wall Street analysts predict that Bioxcel Therapeutics's share price could reach $ by Aug 9, The average Bioxcel Therapeutics stock price. BioXcel Therapeutics Inc. ; Day Range - ; 52 Wk Range - ; Volume, K ; Market Value, $M ; EPS (TTM), -$ Track BioXcel Therapeutics Inc (BTAI) Stock Price, Quote, latest community messages, chart, news and other stock related information.
View BioXcel Therapeutics (BTAI) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Stock Quote & Chart · Stock Quote · Stock Chart · Site - Investor Tools · Cookie Preferences · Privacy Preference Center. When you visit any website, it may. BioXcel Therapeutics, Inc. (Nasdaq: BTAI) is a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience. On average, Wall Street analysts predict that Bioxcel Therapeutics's share price could reach $ by Aug 9, The average Bioxcel Therapeutics stock price. BioXcel Therapeutics, Inc. (installyacija.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock BioXcel Therapeutics. See the latest BioXcel Therapeutics Inc stock price (BTAI:XNAS), related news, valuation, dividends and more to help you make your investing decisions. BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience. BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and. BioXcel Therapeutics (BTAI) - Biopharmaceutical company focused on drug development that utilizes novel artificial intelligence · BioXcel Stock Craters 64% As. Get the latest BioXcel Therapeutics Inc (BTAI) real-time quote, historical performance, charts, and other financial information to help you make more. The current price of BTAI is USD — it has decreased by −% in the past 24 hours. Watch BioXcel Therapeutics, Inc. stock price performance more closely.
BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ. People Also Watch. Vincerx. BTAI | Complete BioXcel Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Stock Data ; Change; (%) ; Volume; , ; Today's Open; $ ; Previous Close; $ BioXcel Therapeutics Inc ; Nov, Downgrade, Goldman, Neutral → Sell, $55 → $24 ; Apr, Initiated, Berenberg, Buy, $ BioXcel Therapeutics Inc. ; Median, $ ; Low, $ ; Average, $ ; Current Price, $ ; Estimate, BioXcel Therapeutics stock quote and BTAI charts. Latest stock price today and the US' most active stock market forums. The average price target for Bioxcel Therapeutics Inc is $ This is based on 4 Wall Streets Analysts month price targets, issued in the past 3 months. Discover real-time BioXcel Therapeutics, Inc. Common Stock (BTAI) stock prices, quotes, historical data, news, and Insights for informed trading and. BioXcel Therapeutics, Inc. (BTAI) ; Aug 26, , , , , ; Aug 23, , , , ,
BioXcel Therapeutics Inc. (BTAI) Stock Performance ; BioXcel Therapeutics (BTAI). , ; S&P Small-Cap , ; BSE Sensex. , BioXcel Therapeutics Inc BTAI:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date11/13/23 · 52 Week. BioXcel Therapeutics (Nasdaq: BTAI) reported its Q2 financial results, highlighting progress in key clinical programs. The company is preparing to initiate. BioXcel Therapeutics stock plummets as 3Q earnings fall short of expectations BioXcel Therapeutics Inc (NASDAQ:BTAI) shares fell almost 35% after it News. BioXcel Therapeutics (BTAI) reported Q1 earnings per share (EPS) of -$, missing estimates of -$ by %. In the same quarter last year, BioXcel.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence. Stock Price Forecast. The 4 analysts with month price forecasts for BTAI stock have an average target of , with a low estimate of and a high. Bioxcel Therapeutics Inc (BTAI) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. BioXcel Therapeutics Inc Resistance and Support ; First Resistance, $ ; Second Resistance, $ ; Third Resistance, $
How To Turn On Toshiba Tv Without Remote | When Is Best Time Of Year To Buy A Car